Home / Indicator library / Biotechnology and Medical Care / INCX (6861) overview
INCX (6861) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for INCX, on one pageINCX (6861) snapshot, key figures
INCX (6861): where today sits in the past year
Current value against the 2025-10-16 to 2026-10-16 range, built from 246 frozen daily vintages.
INCX (6861): where today sits across the whole market
The same figures read against every other listed company on 2026-10-30, rather than against this ticker's own history.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→6861: common questions
What is 6861's P/E ratio?
6861 traded at a price-to-earnings ratio of 32.95x in the official-source snapshot dated 2026-10-30. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 6861's price-to-book ratio?
6861's price-to-book ratio was 5.70x on 2026-10-30, taken as-is from the official public source.
What is 6861's dividend yield?
6861's cash dividend yield was 0.94% on 2026-10-30. Historical dividend policy and gap-fill records are available on the same page.
How fast is 6861's revenue growing?
6861 reported 57.1% year-on-year monthly revenue growth for 2026-09, from the official monthly revenue filing.
Is 6861's price / earnings high or low right now?
6861's price / earnings is 32.95x, which is below its one-year median of 35.92x and sits at the 44th percentile of the 16.10–111.23x range observed over the last 246 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 6861's price / book high or low right now?
6861's price / book is 5.70x, which is above its one-year median of 4.99x and sits at the 62nd percentile of the 1.67–12.41x range observed over the last 246 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
How does 6861's price / earnings compare with the rest of the Taiwan market?
6861's price / earnings of 32.95x is above the market median of 17.63x and sits at the 75th percentile of the 1,543 tickers carrying a valid reading that day — 390 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.
How does 6861's price / book compare with the rest of the Taiwan market?
6861's price / book of 5.70x is above the market median of 1.61x and sits at the 92nd percentile of the 1,085 tickers carrying a valid reading that day — 89 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.
Other Biotechnology and Medical Care tickers
159 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.